Vesicle Therapeutics
PrivateLast Round
Grant
May 21, 2026
Total Funding Raised
$2.57M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Vesicle Therapeutics is a biotechnology company that develops programmable extracellular vesicles, known as gectosomes, to deliver macromolecular therapeutics to intracellular targets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vesicle Therapeutics Comparables
Compare Vesicle Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eascra Biotech | 87% | |
| SHIFTBIO | 82% | |
| Carus Bio | 82% | |
Vesicle Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 21, 2026 | ||||
| Grant | Sep 16, 2025 | ||||
| Grant | Oct 28, 2024 | ||||
| Grant | May 19, 2022 | ||||
| Grant | May 1, 2022 | ||||
Seed | Apr 5, 2022 |
Vesicle Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Venture Partners at CU Boulder | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2026
$250K grant round completed.
- Sep 16, 2025
$400K grant round completed.
Vesicle Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vesicle Therapeutics's valuation, stock price, and market status.